Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study

European Journal of Cancer Part A

Volumn 32, Issue 7, 1996, Pages 1125-1128

  Filella, X ^a   Molina, R ^a   Ballesta, A M ^a   Gil, M J ^b   Allepuz, C ^b   Rioja, L A ^b   Perez B ^c   Esquerda, A ^c   Guajardo, J ^c   Zulueta, M L ^d   Flores, N ^d   Gallego, J ^e   Genolla J ^f   Aranburu, I ^f   Arruza, A ^f   Corominas, A ^g   Pastor, M C ^g   Comet, J ^g   Enguidanos, M J ^h   Jimenez J ^h   Ortiz, B ⁱ   Casanova, J ⁱ   Solsona, E ⁱ   Palazon J ^j   Salas, A ^j   Ballesteros, J J ^j   Vidriales, I ^k   Larrodera, M L ^k   Leyva, O ^k   Garcia C ^l   Gonzalez M ^l   Ortiz, J ^m   Marcos, M L ^m   Carballido, J ^m   Casero, C ⁿ   Alonso, A ⁿ   Chicharro, J A ⁿ   Milena, A ^o   Gonzalez C ^o   Concepcion T ^o   Salcedo, E ^p   Sebastian, J L ^p   Blanco, N ^q   Canadas E ^q   Cozar, J M ^q   Silva, C ^r   Cruz, M ^r   Camacho, E ^r   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

^d Hospital Basurto   (Mexico)

^e Hospital de Castellón   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^j Lab de Referencia de Cataluña   (Spain)

^k HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^l Nutrition Unit Policlínica Sagasta   (Spain)

^m HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁿ HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^o HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^p Universidad Pública de Navarra   (Spain)

^q HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^r HOSPITAL UNIVERSITARIO DE VALME   (Spain)

more..

Author keywords

prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030176253     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00092-5     Document Type: Article

References (20)

1. 1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979, 17, 159-163.
2. 2. Yu, H, Diamandis EP, Sutherland D JA. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994, 27, 75-79.
3. 3. Yu, H, Diamandis EP. Prostate-specific antigen in milk of lactating women. Clin Chem 1995, 41, 54-58.
4. 4. Ambruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993, 39, 181-195.
5. 5. Ruckle HC, Kleee GC, Oesterling JE. Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy. Mayo Clin Proc 1994, 69, 69-79.
6. 6. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991, 324, 1156-1161.
7. 7. Labrie F, Dupont A, Suburu R, et al. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992, 147, 846-852.
8. 8. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostate carcinoma with prostate specific antigen. J Urol 1992, 147, 841-854.
9. 9. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994, 151, 1283-1290.
10. 10. Colberg JW, Catalona WJ. Incidence of prostate cancer in men with PSA levels of 2.9 to <4 ng/ml (Abstract). J Urol 1991, 145, 382A.
11. 11. Morote J, Ruibal A, Palou J. Evaluation of specific antigen and prostatic acid phosphatase specificity. Study of false values. Int J Biol Markers 1986, 1, 141-146.
12. 12. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. Prostate specific antigen and prostate acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 1987, 138, 1181-1184.
13. 13. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989, 142, 1011-1017.
14. 14. Filella X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM. Clinical usefulness of prostate specific antigen and prostatic acid phosphatase. Tumor Biology 1990, 11, 289-295.
15. 15. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995, 273, 289-294.
16. 16. Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992, 267, 2215-2220.
17. 17. Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992, 147, 815-816.
18. 18. Benson MC, Whang IS, Olsson CA, Mcmahon D, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992, 147, 817-821.
19. 19. Filella X, Alcover J, Molina R, Carrere W, Carretero P, Ballesta AM. Usefulness of prostate specific antigen density as a diagnostic test of prostate cancer. Tumor Biology 1996, 17, 20-26.
20. 20. Christensson A, Björk T, Nilsson O, et al. Serum prostate specific antigen complexed to alfa-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993, 150, 100-105.